Temazepam: Side Effects, Uses & Monitoring

Temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days).

Data source
FDA labeling via NIH DailyMed (label 6248295e…)
Label version
current
Last reviewed
2026
Side effects

Reported adverse reactions

Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.

Adverse reaction (as reported in labeling)Reported frequency*
Drowsiness9.1%
Headache9.1%
Nervousness8.2%
Fatigue4.8%
Lethargy4.5%
Dizziness4.5%
Nausea3.8%
Hangover2.5%
Dry mouth2.2%
Anxiety2%
Abdominal discomfort1.9%
Depression1.8%
Diarrhea1.7%
Nightmares1.7%
Euphoria1.5%
Weakness1.4%
Confusion1.3%
Blurred vision1.3%
Vertigo1.2%

*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.

Uses

Labeled uses (from FDA prescribing information)

Temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that temazepam capsules should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.

Related conditions

Conditions associated with Temazepam in labeling

FAQ

Frequently Asked Questions

What is Temazepam used for?

FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.

What are the most commonly reported side effects of Temazepam?

The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Temazepam. Individual risk varies.

Does Temazepam require lab monitoring?

Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Temazepam.

Where does this information come from?

All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.

Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.

Educational content only: The information on Symptom Database.com is for educational purposes and is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Read our full disclaimer.